43.8 F
New York
Sunday, January 29, 2023



Vesalio Appoints VP of U.S. Sales and Announces Recent Publication on NeVa Showing Impressive First Pass Rates

Related Articles

ez1095 Streamlines 1094 and 1095 ACA Form Reporting Ahead of Deadline

Seattle, WA, January 28, 2023 --(PR.com)-- The new edition of ez1095 software from halfpricesoft offers employers and tax professionals a user-friendly and efficient way to...

Blockchain of Things, Inc. Set to Open-Source Their Blockchain Building Platform. Catenis is Now Open Source.

Miami, FL, January 27, 2023 --(PR.com)-- Blockchain of Things (BCoT), has announced that its Catenis platform is now entirely open-source with an MIT commercial use...

Teche Solutions Launching TecheBOARD – an Intelligent Motherboard for Smarter Solutions

Miami, FL, January 26, 2023 --(PR.com)-- Teche Solutions, (https://teche.solutions/techeboard/) an innovative enterprise IoT solutions provider in the embedded computing marketplace, is pleased to launch the...
Nashville, TN, November 29, 2022 –(PR.com)– Vesalio is pleased to welcome Bob Bushok as Vice President of U.S. Sales overseeing commercial strategy and execution for the NeVa VSTM vasospasm launch and the expected 2023 introduction of NeVa™ thrombectomy platform into the U.S. market. Bob will be responsible for building the U.S. sales team and will play a pivotal role in continuing to grow the company through strategic initiatives.

Bob brings Vesalio 20 years of sales leadership experience in the neurovascular space from major player Medtronic to several successful start-ups, including Concentric, EV3, and Viz.AI. In his most recent role as Senior Director at Viz.AI, Bob was responsible for integrated delivery networks (IDNs), national accounts, and pioneering AI use to increase the speed and access to care in acute ischemic stroke. “I have been following Vesalio’s successful international development with great interest…

Read more…

Popular Articles